Table 1 Univariate and multivariate analysis of clinico-pathological parameters for the prediction of 5-year OS in patients with diffuse large B-cell lymphoma (n=477)
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
Parameter | HR (95% CI) | P -value | HR (95% CI) | P -value |
Gender | ||||
Female (n=287) | 1 (referent) | 0.026 | 1 (referent) | 0.212 |
Male (n=190) | 0.691 (0.50–0.957) | 0.81 (0.58–1.13) | ||
Age at diagnosis (years) | ||||
<60 (n=180) | 1 (referent) | <0.001 | 1 (referent) | 0.015 |
⩾60 (n=297) | 2.86 (1.90–4.3) | 1.77 (1.12–2.81) | ||
Clinical stage (Ann Arbor) | ||||
I and II (n=248) | 1 (referent) | <0.001 | 1 (referent) | 0.802 |
III and IV (n=229) | 1.86 (1.34–2.6) | 1.06 (0.68–1.65) | ||
R-IPI | ||||
Very good+good (n=293) | 1 (referent) | <0.001 | 1 (referent) | 0.003 |
Poor (n=184) | 2.86 (2.06–3.98) | 2.02 (1.28–3.21) | ||
CRP | ||||
<15 mg l−1 (n=266) | 1 (referent) | <0.001 | 1 (referent) | 0.031 |
⩾15 mg l−1 (n=211) | 2.43 (1.74–3.39) | 1.51 (1.04–2.20) | ||
dNLR a | ||||
<4 (n=367) | 1 (referent) | 0.018 | 1 (referent) | 0.205 |
⩾4 (n=85) | 1.58 (1.08–2.31) | 1.28 (0.87–1.89) |